Together we will beat cancerDonate
Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.
Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.
Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England.
Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.
An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS.
Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto
A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today.
A cancer vaccine personalised to individual patients could reduce the chances of a type of blood cancer from returning, a small US study has found.
Researchers studying the genetic make-up of an aggressive blood cancer, AML, have discovered that it exists in at least 11 different forms.
A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer.